Share

Trump's week in review: Cuts TPS status for South Sudan; Nigerian pres. responds to threat over Christian persecution

By Ryan Foley, Christian Post Reporter
U.S. President Donald Trump speaks during an event about weight-loss drugs in the Oval Office of the White House in Washington, D.C. on Nov. 6, 2025. President Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs. Both companies "have agreed to offer their most popular GLP-1 weight-loss drug," Trump said, "at drastic discounts."
U.S. President Donald Trump speaks during an event about weight-loss drugs in the Oval Office of the White House in Washington, D.C. on Nov. 6, 2025. President Trump announced deals Thursday with pharmaceutical giants Eli Lilly and Novo Nordisk to lower the prices of some popular weight-loss drugs. Both companies "have agreed to offer their most popular GLP-1 weight-loss drug," Trump said, "at drastic discounts." | ANDREW CABALLERO-REYNOLDS/AFP via Getty Images)

While elections resulting in expected victories for Democrats dominated headlines this week as the nation continues to experience fallout from the government shutdown, events this week also saw President Donald Trump speak out in defense of persecuted Christians in Nigeria and take action on immigration policy and prescription drug pricing. 

Here are five highlights from this week. 

Ryan Foley is a reporter for The Christian Post. He can be reached at: ryan.foley@christianpost.com

You’ve readarticles in the last 30 days.

Was this article helpful?

Help keep The Christian Post free for everyone.

Our work is made possible by the generosity of supporters like you. Your contributions empower us to continue breaking stories that matter, providing clarity from a biblical worldview, and standing for truth in an era of competing narratives.

By making a recurring donation or a one-time donation of any amount, you’re helping to keep CP’s articles free and accessible for everyone.

We’re sorry to hear that.

Hope you’ll give us another try and check out some other articles. Return to homepage.

Most Popular

More Articles